Skip to Content
Merck
  • Efficacy of sulfamethoxypyridazine in a murine model of Pneumocystis carinii pneumonia.

Efficacy of sulfamethoxypyridazine in a murine model of Pneumocystis carinii pneumonia.

Antimicrobial agents and chemotherapy (1998-04-29)
M S Bartlett, M M Shaw, J W Smith, S R Meshnick
ABSTRACT

Sulfamethoxazole is the component of co-trimoxazole responsible for its efficacy against Pneumocystis carinii pneumonia, but this drug is associated with frequent adverse effects. Sulfamethoxypyridazine is significantly more effective than sulfamethoxazole against a murine model of P. carinii and might be a candidate for testing in infected patients.

MATERIALS
Product Number
Brand
Product Description

Supelco
Sulfamethoxypyridazine, VETRANAL®, analytical standard